[{"type": "title", "data": "Vaccinations Post-Emergent Splenectomy"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Vaccinations should be given at least 14 days post-splenectomy to optimize the immune response. If discharge is prior to POD14, and there is concern the patient may not present later for vaccination, vaccinations can be given prior to discharge "}, {"type": "note", "data": "If patient has received PNEUMOVAX-23 within past 12 months, DO NOT administer pneumococcal 13-valent conjugate (PREVNAR-13) until 1 year after last dose of PNEUMOVAX-23 "}, {"type": "order", "data": "pneumococcal 13-valent conjugate vaccine intramuscular suspension", "value": ""}, {"type": "sentence", "data": "0.5 mL, IM, Injection, As directed"}, {"type": "order", "data": "meningococcal conjugate vaccine group ACYW intramuscular injection", "value": ""}, {"type": "sentence", "data": "0.5 mL, IM, Injection, As directed"}, {"type": "order", "data": "haemophilus b conjugate (PRP-T) vaccine", "value": ""}, {"type": "sentence", "data": "0.5 mL, IM, Injection, As directed"}, {"type": "note", "data": "Inform the patient that while the meningococcal B vaccine is currently not part of the protocol of the British Columbia Centre of Disease Control and Prevention guidelines for asplenia, the vaccine is available in the community. The meningococcal B vaccine could provide additional protection against meningococcal sepsis for patients that want the immunization "}]
